Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study

Yang, WR; Zhao, X; He, GS; Chang, H; Han, B; Gao, SJ; Wang, SQ; Chen, T; Li, F; Wang, Y; Ge, XY; Fu, R; Ge, Z; Li, YM; Liu, H; Liu, XJ; Miao, M; Zhang, LS; Zhang, FK

Zhang, FK (通讯作者)，Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, State Key Lab Expt Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China.;Zhang, FK (通讯作者)，Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst, 288 Nanjing Rd, Tianjin 300020, Peoples R China.

ANNALS OF HEMATOLOGY, 2022; 101 (12): 2611

Abstract

Hetrombopag is the only CFDA-approved thrombopoietin (TPO) receptor agonist for severe aplastic anemia (SAA) in China. Its chemical structure has an i......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索